Man Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Sell |
8,969
-1,064
| -11% | -$42K | ﹤0.01% | 1698 |
|
|
2025
Q1 | $303K | Buy |
10,033
+1,718
| +21% | +$51.8K | ﹤0.01% | 1708 |
|
|
2024
Q4 | $291K | Sell |
8,315
-587,948
| -99% | -$20.6M | ﹤0.01% | 1649 |
|
|
2024
Q3 | $23.9M | Sell |
596,263
-37,146
| -6% | -$1.49M | 0.06% | 364 |
|
|
2024
Q2 | $30.2M | Buy |
633,409
+380,188
| +150% | +$18.1M | 0.08% | 285 |
|
|
2024
Q1 | $11M | Buy |
253,221
+174,746
| +223% | +$7.58M | 0.03% | 637 |
|
|
2023
Q4 | $3.97M | Buy |
+78,475
| New | +$3.97M | 0.01% | 975 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 736 |
|
|
2023
Q2 | – | Hold |
0
| – | -$8.95M | – | 2036 |
|
|
2023
Q1 | – | Sell |
-230,525
| Closed | -$8.71M | – | 591 |
|
|
2022
Q4 | $8.71M | Buy |
230,525
+52,928
| +30% | +$2M | 0.03% | 628 |
|
|
2022
Q3 | $7.86M | Buy |
+177,597
| New | +$7.86M | 0.04% | 562 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1566 |
|
|
2020
Q4 | – | Sell |
-6,204
| Closed | -$294K | – | 1876 |
|
|
2020
Q3 | $294K | Sell |
6,204
-109,808
| -95% | -$5.2M | ﹤0.01% | 1632 |
|
|
2020
Q2 | $6.84M | Buy |
116,012
+106,312
| +1,096% | +$6.27M | 0.03% | 520 |
|
|
2020
Q1 | $459K | Sell |
9,700
-48,970
| -83% | -$2.32M | ﹤0.01% | 1285 |
|
|
2019
Q4 | $3.54M | Buy |
58,670
+4,422
| +8% | +$267K | 0.01% | 1119 |
|
|
2019
Q3 | $3.25M | Sell |
54,248
-28,707
| -35% | -$1.72M | 0.01% | 1066 |
|
|
2019
Q2 | $5.33M | Buy |
82,955
+62,031
| +296% | +$3.99M | 0.02% | 917 |
|
|
2019
Q1 | $1.7M | Buy |
20,924
+15,800
| +308% | +$1.28M | 0.01% | 1391 |
|
|
2018
Q4 | $277K | Sell |
5,124
-6,953
| -58% | -$376K | ﹤0.01% | 1740 |
|
|
2018
Q3 | $623K | Sell |
12,077
-6,032
| -33% | -$311K | ﹤0.01% | 1780 |
|
|
2018
Q2 | $755K | Buy |
18,109
+13,509
| +294% | +$563K | ﹤0.01% | 1672 |
|
|
2018
Q1 | $203K | Buy |
+4,600
| New | +$203K | ﹤0.01% | 1899 |
|